Not exact matches
In the new paper, Kajimura's team collaborated with the laboratory
of Yasushi Ishihama, PhD,
of the University
of Kyoto, Japan, to search for differences in how white and brown fat cells respond to the cold using a technique called
phosphoproteomics.
This visual abstract depicts how Wei et al. utilize single - cell
phosphoproteomic analysis
of patient derived glioblastoma models to identify shifts in signaling coordination following short - term treatment with kinase inhibitors, which facilitates the design
of combination therapy approaches with reduced resistance and improved efficacy.
In the paper, the researchers also described that single - cell
phosphoproteomics could be used to study how melanoma cells develop resistance to a class
of drugs called BRAF inhibitors.
Evan Paull, a graduate student in Stuart's lab at UC Santa Cruz (now at Columbia University), led the computational analyses, which involved integrating the
phosphoproteomic data with genomic and gene expression datasets to provide a unified view
of the activated signaling pathways in late stage prostate cancer.
«Having the
phosphoproteomics data in addition to the traditional genomics and transcriptomics enabled us to get a more comprehensive view
of aberrant signaling in this disease,» Paull said.
Applying these methods to prostate cancer cell lines, the researchers found that accurate predictions
of drug sensitivity could be achieved using either genomics data or
phosphoproteomics data alone.
The transcriptomics and
phosphoproteomics data generated by this project will allow the identification
of novel host and parasite genes and pathways that play a key role during infection.
Phosphoproteomic Analysis Reveals the Importance
of Kinase Regulation During Orbivirus Infection.
Her interests centre on developing methods for quantitative proteomics,
phosphoproteomics and methods for tracking changes in sub-cellular localization
of the proteome in response to cell signalling events.
Proteomics and
phosphoproteomics analyses in melanoma cells identified CDK2 as a driver
of resistance to both BRAF and Hsp90 inhibitors.
He has also been leading statistical data analysis for the Broad Institute's Proteome Characterization Center and Proteogenomic Data Analysis Center established under the National Cancer Institute Clinical Proteomics Tumor Analysis Consortium (CPTAC), focusing on proteogenomic analysis
of proteomic,
phosphoproteomic, and genomic data derived from cancer samples.
A Library
of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations.